Announcements Trials
Browse Landscape

Status

Completed 5Unknown 2Enrolling by invitation 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 2

Sponsor

Cancer Type

Other 1Dermatologic 1

Conditions

Smoking 1Pulmonary Disease, Chronic Obstructive 1Overweight 1Obesity 1Noncommunicable Diseases 1Neoplasms 1Melanoma 1Hypokinesia 1Hypertension 1Hyperglycemia 1Dyslipidemias 1Diabetes Mellitus 1Coronary Disease 1Cerebrovascular Disorders 1Cardiotoxicity 1Asthma 1Alcohol Drinking 1

Interventions

Specimen Handling 5Surveys and Questionnaires 4Observation 4Blood Specimen Collection 4Drug Therapy 3Chemoradiotherapy 3Surgical Procedures, Operative 2Electrocardiography 2Echocardiography 2Capecitabine 2Biopsy 2trifluridine tipiracil drug combination 1tegafur-gimeracil-oteracil 1somapacitan 1olverembatinib 1lorlatinib 1lenvatinib 1gallium 68 PSMA-11 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1Zoledronic Acid 1Tumor Burden 1Telemedicine 1Tegafur 1Stents 1Spermine Synthase 1S 1 (combination) 1Robotic Surgical Procedures 1Rituximab 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Electrocardiography × Clear all
NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation
60 enrolled
Dermatologic

Melanoma, Cardiotoxicity

NCT06812767 2025-02-06

FORTUNE

National Medical Research Center for Therapy and Preventive Medicine

Enrolling by invitation
2,000 enrolled
Other

Noncommunicable Diseases, Alcohol Drinking, Asthma, Cerebrovascular Disorders, Coronary Disease, Diabetes Mellitus, Hyperglycemia, Hypertension, Neoplasms, Obesity, Smoking, Hypokinesia, Pulmonary Disease, Chronic Obstructive, Dyslipidemias, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡